Intrinsiqs

Is Heron Therapeutics, Inc. overvalued?

Heron Therapeutics, Inc. (HRTX) — key valuation metrics and fundamentals.

No verdict
Price
$0.34
Fair value
—
Current P/E
—
Normal P/E
28.6
Market cap
$63.7M
Dividend yield
0.0%
Return on equity
-300.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares HRTX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.